$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
美国礼来制药的雷莫芦单抗需要用多久?
2025-10-19 11:44:20
Check Details
ctDNA可预测I - III期结直肠癌术后疾病复发风险
2025-10-19 11:44:20
Check Details
人工智能有助于识别早发性结直肠癌的新危险因素
2025-10-19 11:44:20
Check Details
碧康瑞格非尼价格
2025-10-19 11:44:20
Check Details
碧康瑞格非尼效果怎么样?
2025-10-19 11:44:20
Check Details
瑞格非尼适用于什么病症?
2025-10-19 11:44:20
Check Details
礼来制药的雷莫芦单抗安全性怎么样?
2025-10-19 11:44:20
Check Details
高危II期结直肠癌辅助双重化疗:3个月还是6个月?
2025-10-19 11:44:20
Check Details
瑞格非尼购买途径
2025-10-19 11:44:20
Check Details
碧康瑞格非尼的价格
2025-10-19 11:44:20
Check Details
碧康瑞格非尼多少粒一盒?
2025-10-19 11:44:20
Check Details
瑞格非尼靠谱吗?
2025-10-19 11:44:20
Check Details
1
2
...
1610
1611
1612
1613
1614
1615
1616
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
4
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
5
Complete Guide to Dosage and Dose Adjustment of Entrectinib
6
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
7
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
8
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
9
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
10
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
11
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
12
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety